Johnson & Johnson Vision to Showcase New Data and Interactive Experiences at 2019 American Academy of Optometry Annual Meeting

Johnson&Johnson VISION
  • New study data shows more than 90% of spectacle wearers preferACUVUE® OASYS with Transitions contact lenses as part of their habitual vision correction
  • Clinical Research Fellow Dr. Noel Brennan reveals new science to advance discussions about myopia control methods.
  • The Johnson & Johnson Vision booth will host a variety of interactive experiences including product trials, hands-on demonstrations and education

JACKSONVILLE, Fla. October 21, 2019– Johnson & Johnson Vision will be sharing new science and clinical practice information to advance treatment paradigms and vision outcomes together with eye care professionals at the 2019 American Academy of Optometry Annual Meeting, held October 23 - 27 in Orlando, Florida.

“We're excited to lead in the exchange of new ideas informed by data and science," said Thomas Swinnen, President, North America, Johnson & Johnson Vision Care, Inc. “We're profiling new evidence that shows spectacle wearers who have never worn contact lenses covet the experience they had with our ACUVUE® OASYS with Transitionscontact lenses and other data to advance discussions around current myopia control methods and measure. These studies offer two diverse examples of our commitment to empower eye care professionals with new information.”

Scientific Presentations

Johnson & Johnson Vision and its collaborators will present several papers and posters at Academy 2019 including the new study focused on photochromic contact lenses, new science around the growing prevalence and impact of myopia and advancing discussions around the need for more evidence-based treatment measures to help address this public health threat.

ACUVUE® OASYS with Transitions

Johnson & Johnson Vision will be debuting the results of a new study around ACUVUE® OASYS with Transitions contact lenses which reveals that the benefits of this first-of-its-kind light adaptive lens were deemed highly valued by people who had never worn contact lenses, and that most study participants preferred to have the ACUVUE® OASYS with Transitions contact lenses as part of their habitual vision correction.

John R. Buch, OD, MS, FAAO and Senior Principal Research Optometrist at Johnson & Johnson Vision Care, Inc. will present findings from the study, “Performance and Acceptance of Senofilcon A with Photochromic Additive on a Neophyte Population,” on Thursday, October 24, 4:30 - 6:30 p.m., Exhibit Hall WD1 Board #131.

Myopia Health Outcomes & Treatment Insights

Given its aspiration to halt the myopia epidemic, Noel A. Brennan, MScOptom, PhD, FAAO and Clinical Research Fellow at Johnson & Johnson Vision Care, Inc., is presenting new science and advancing discussions around current myopia control methods and measures and the need for evidence-based criteria to inform treatment decision making for practitioners.

Dr. Brennan will present findings from the study, “Safety of Contact Lenses in Pediatrics: Data Analysis from Six Randomized Myopia Control Trials,” on Thursday, October 24, 4:30 - 6:30 p.m. Exhibit Hall WD1 Board #172. This will also be included in the myopia super hybrid paper/poster session from 9 a.m. - noon, Room W224 ABC, Board #1.

This study analyzed ocular adverse event data from six randomized controlled trials among a total of 663 myopic children (aged 7 - 15 years at baseline) who were administered daily disposable hydrogel (etafilcon A) contact lenses. The rate of adverse events among these children was similar to, if not less than, that which has been previously observed among adults.

Interactive Experiences in Booth #1201

At Academy 2019, the Johnson & Johnson Vision exhibit booth will host a variety of interactive experiences including product promotions, hands-on demonstrations and education, including a one-of-a-kind light simulation that will ‘teleport’ visitors to exotic locations where they can see first-hand the unique benefits of ACUVUE® OASYS with Transitions Light Intelligent Technology and how the contact lens works to provide superior visual performanceǂ in real-time demonstrations across various lighting conditions.

Connect-and-Learn Events

Johnson & Johnson Vision is proud to sponsor events during the meeting that bring together members of the optometric community for access to the latest advances and to support and learn from each other.

  • Industry Innovation Lunch & Learn - “Innovation to Build Your Practice” Wednesday, October 23, Noon - 12:45 p.m. at the Hyatt Orlando Ballroom N, Conv.       Carol Alexander, OD, FAAO and Head of North America Professional Relations, Johnson & Johnson Vision Care, Inc., will present the latest innovation from ACUVUE® and how innovation can be a catalyst for practice growth.
  • Residency & Graduate Program Fair     Friday, October 25, Noon - 3 p.m. at the Valencia Ballroom W415CD, Level IV        This year the focus will be on building your brand, increasing your visibility and solidifying your recruiting pipeline. As a sponsor, Johnson & Johnson Vision will have a branded area for networking during the event.
  • Resident & Practitioner Match Event      Friday, October 25, 5 - 6:30 p.m. at the Regency Ballroom PQ, Convention Level, Hyatt Regency Johnson & Johnson Vision is proud to sponsor this opportunity for residents and doctors to meet, talk and connect.

For more information about Johnson & Johnson Vision at Academy 2019, visit

Johnson & Johnson Vision

At Johnson & Johnson Vision, part of Johnson & Johnson Medical Devices Companies,* we have a bold ambition: to change the trajectory of eye health around the world. Through our operating companies, we deliver innovation that enables eye care professionals to create better outcomes for patients throughout their lives, with products and technologies that address unmet needs including refractive error, cataracts and dry eye. In communities with greatest need, we work in collaboration to expand access to quality eye care, and we are committed to helping people see better, connect better and live better. Visit us at Follow @JNJVision on Twitter and Johnson & Johnson Vision on LinkedIn.

About Johnson & Johnson Medical Devices Companies*
At Johnson & Johnson Medical Devices Companies, we are helping people live their best lives. Building on more than a century of expertise, we tackle pressing healthcare challenges, and take bold steps that lead to new standards of care while improving people’s healthcare experiences. In surgery, orthopaedics, vision and interventional solutions, we are helping to save lives and paving the way to a healthier future for everyone, everywhere.

* The Johnson & Johnson Medical Devices Companies comprise the surgery, orthopaedics, vision and interventional solutions businesses within Johnson & Johnson’s Medical Devices segment.  


Compared to not wearing contact lenses/spectacles alone.

ǂCompared to ACUVUE® OASYS 2-WEEK with Hydraclear® Plus.

Helps protect against transmission of harmful UV radiation to the cornea and into the eye.

WARNING: UV-absorbing contact lenses are NOT substitutes for protective UV-absorbing eyewear such as UV-absorbing goggles or sunglasses because they do not completely cover the eye and surrounding area. You should continue to use UV-absorbing eyewear as directed. NOTE: Long-term exposure to UV radiation is one of the risk factors associated with cataracts. Exposure is based on a number of factors such as environmental conditions (altitude, geography, cloud cover) and personal factors (extent and nature of outdoor activities). UV-blocking contact lenses help provide protection against harmful UV radiation. However, clinical studies have not been done to demonstrate that wearing UV-blocking contact lenses reduces the risk of developing cataracts or other eye disorders. Consult your eye care practitioner for more information.

Lenses are not a replacement for sunglasses.

Important Information for Contact Lens Wearers: ACUVUE® Brand Contact Lenses are only available by prescription for vision correction as a daily wear lens with two-week recommended replacement. An eye care professional will determine whether contact lenses are right for you. Although rare, serious eye problems can develop while wearing contact lenses. To help avoid these problems, follow the wear and replacement schedule and lens care instructions provided by your eye doctor. Do not wear contact lenses if you have an eye infection, or experience eye discomfort, excessive tearing, vision changes, redness or other eye problems. If one of these conditions occurs, remove the lens and contact your eye doctor immediately. For more information on proper wear, care and safety, talk to your eye care professional and ask for a Patient Instruction Guide, call 1-800-843-2020 or visit

The third-party trademarks used herein are trademarks of their respective owners. Transitions, the Transitions logo and Transitions Light Intelligent Technology are trademarks of Transitions Optical, Inc. used under license by Transitions Optical Limited and Johnson & Johnson Vision Care, Inc.

ACUVUE® is a registered trademark of Johnson & Johnson Vision Care, Inc.

©Johnson & Johnson Vision Care, Inc. 2019.


For further information, contact:

Meghan Harding



Angela Sekston